MY153262A - Amino-piperidine derivatives as cetp inhibitors - Google Patents

Amino-piperidine derivatives as cetp inhibitors

Info

Publication number
MY153262A
MY153262A MYPI20090048A MYPI20090048A MY153262A MY 153262 A MY153262 A MY 153262A MY PI20090048 A MYPI20090048 A MY PI20090048A MY PI20090048 A MYPI20090048 A MY PI20090048A MY 153262 A MY153262 A MY 153262A
Authority
MY
Malaysia
Prior art keywords
amino
piperidine derivatives
cetp inhibitors
cetp
compound
Prior art date
Application number
MYPI20090048A
Other languages
English (en)
Inventor
Imase Hidetomo
Yasoshima Kayo
Iwaki Yuki
Kawanami Toshio
Miyake Takahiro
Mogi Muneto
Ohmori Osamu
Qin Hongbo
Umemura Ichiro
Yamada Ken
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of MY153262A publication Critical patent/MY153262A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MYPI20090048A 2006-07-20 2007-07-18 Amino-piperidine derivatives as cetp inhibitors MY153262A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06117541 2006-07-20
US88705807P 2007-01-29 2007-01-29

Publications (1)

Publication Number Publication Date
MY153262A true MY153262A (en) 2015-01-29

Family

ID=37680601

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20090048A MY153262A (en) 2006-07-20 2007-07-18 Amino-piperidine derivatives as cetp inhibitors

Country Status (13)

Country Link
KR (1) KR20120034774A (zh)
CN (1) CN101490035B (zh)
BR (1) BRPI0714516A2 (zh)
DK (1) DK2049517T3 (zh)
ES (1) ES2449571T3 (zh)
MY (1) MY153262A (zh)
NZ (1) NZ573439A (zh)
PT (1) PT2049517E (zh)
RU (1) RU2442782C2 (zh)
SG (1) SG173378A1 (zh)
SI (1) SI2049517T1 (zh)
UA (1) UA96942C2 (zh)
ZA (1) ZA200810008B (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112898257B (zh) * 2021-03-12 2023-01-24 天津理工大学 一种水溶性香豆素衍生物内盐的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2719311B1 (fr) * 1994-03-18 1998-06-26 Sanofi Sa Composés antagonistes sélectifs du récepteur NK3 humain et leur utilisation comme médicaments et outils de diagnostic.
US6140342A (en) * 1998-09-17 2000-10-31 Pfizer Inc. Oxy substituted 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinolines

Also Published As

Publication number Publication date
DK2049517T3 (en) 2014-03-03
CN101490035B (zh) 2013-02-13
BRPI0714516A2 (pt) 2014-07-08
UA96942C2 (uk) 2011-12-26
RU2009105763A (ru) 2010-08-27
SI2049517T1 (sl) 2014-04-30
SG173378A1 (en) 2011-08-29
CN101490035A (zh) 2009-07-22
KR20120034774A (ko) 2012-04-12
ES2449571T3 (es) 2014-03-20
ZA200810008B (en) 2009-11-25
NZ573439A (en) 2012-02-24
PT2049517E (pt) 2014-03-10
RU2442782C2 (ru) 2012-02-20

Similar Documents

Publication Publication Date Title
TN2009000012A1 (en) Amino-piperidine derivatives as cetp inhibitors
JO2732B1 (en) Organic compounds
MX2010006063A (es) Derivados de 4-bencil-amino-pirrolidina 1,2-disustituida como inhibidores de la proteina de transferencia de colesteril-ester (cetp) utiles para el tratamiento de las enfermedades tales como hiperlipidemia o arterioesclerosis.
MX2009006630A (es) Derivados de 4-imidazolil-1,2,3,4-tetrahidro-quinola y su uso como inhibidores de aldosterona / 11-beta-hidroxilasa.
MX2009003834A (es) Derivados de pirrolidina como inhibidores de iap.
MX2009006481A (es) Derivados de imidazol 1-sustituidos, y su uso como inhibidores de la sintasa de aldosterona.
MX2012002752A (es) Compuestos de heteroarilo como inhibidores de cinasa.
MA33776B1 (fr) Dérivés arylecarbonyle et hétéroarylcarbonyle d'hexahydroindénopyridine et d'octahydrobenzoquinoline
MX2011011854A (es) Dihidropirimidinonas para uso como inhibidores de la bace2.
SG171593A1 (en) Inhibitors of c-fms kinase
GEP20115306B (zh)
TNSN08444A1 (en) Bicyclic derivatives as cetp inhibitors
GEP20146004B (en) Pyridazinone compounds
ATE542813T1 (de) 6-substituierte 2- heterocyclylaminopyrazinverbindungen als chk-1- inhibitoren
JO3007B1 (ar) مركبات و تركيبات كمثبطات كيناز بروتين
MX2009005795A (es) Composiciones, sintesis y metodos para usar inhibidores de colinesterasa basados en indanona.
MX2009009699A (es) Compuestos amino-5-[4-(difluorometoxi)fenil sustituidos]-5-fenilim idazolona como inhibidores de beta-secretasa.
MX2009004822A (es) Compuestos de fenilpropionamida y usos de los mismos.
IN2012DN01273A (zh)
IL198901A0 (en) Pyrimidine derivatives and multiple myeloma
GEP20146201B (en) Heteroaromatic aryl triazole derivatives as pde10a enzyme inhibitors
MX2009004982A (es) Derivados heterociclicos como inhibidores cetp.
ATE517873T1 (de) 6-oxo-1,6-dihydropyrimidin-2-yle bei der behandlung proliferativer krankheiten
MX2009005249A (es) Compuestos organicos.
DE602007011434D1 (de) 1h-indol-5-ylpiperazin-1-ylmethanonderivate